MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Patient-reported Symptoms and their Impact in Hereditary Spastic Paraplegia and Spastic Ataxias

    M. Ademi, C. Dubec-Fleury, J. Morales Saute, J. Greenfield, R. Wallis, C. Gobeil, L. Renna Linton, A. Nadke, R. Horvath, F. Santorelli, B. de Warrenburg, M. Synofzik, S. Du Montcel, P. Consortium, R. Schüle (Heidelberg, Germany)

    Objective: To understand health impacts relevant to patients with hereditary spastic paraplegia (HSP) and spastic ataxia (SPAX) by determining the prevalence and relative importance of…
  • 2025 International Congress

    Subthalamotomy and thalamotomy using MgFUS: Retrospective review of 9 years of treating Parkinson’s disease and Essential Tremor.

    C. Del Toro-Pérez, R. Martínez-Fernández, E. Natera-Villalba, R. Rodriguez-Rojas, J. Pineda-Pardo, C. Gasca Salas, M. Matarazzo, JA. Obeso Inchausti (Madrid, Spain)

    Objective: To report a 9-year single-center experience using MRgFUS thermoablation for movement disorders. Background: Over 22000 patients with Essential Tremor (ET), Parkinson´s disease (PD) and…
  • 2025 International Congress

    Improvement in Chorea After Transcarotid Artery Revascularization: A Case Report

    A. Bossart, A. Baddour, D. Renner, J. Alshaikh (Salt Lake City, USA)

    Objective: To describe a case of acute onset chorea in a patient with significant right carotid stenosis with resolution of symptoms post transcarotid artery revascularization…
  • 2025 International Congress

    Retrospective series of adult-onset myoclonus presenting to an outpatient movement disorders clinic

    M. Hamed, K. Oh, D. Zarandi, M. Oluleye, A. Zaher, J. Elsaygh, S. Rizly, X. Ma, H. Ooi, H. Sarva, M. Salgado, D. Victor (Brooklyn, USA)

    Objective: To describe the phenomenology, etiology and treatment response in adults presenting to our clinic with myoclonus. Background: Myoclonus in the inpatient setting range often…
  • 2025 International Congress

    A Standardised, Semi-automated Computational Approach to the Analysis of Electrophysiology in Orthostatic Myoclonus

    N. Jeyakumar, S. Nagaratnam, G. Jeyakumar, P. Becker, F. Chang, V. Fung (Westmead, Australia)

    Objective: We sought to develop a standardised, computationally tractable approach to the analysis of electrophysiology in orthostatic myoclonus by developing novel definition criteria for myoclonic…
  • 2025 International Congress

    Novel heterozygous variant in VPS13A: First case report of choreoacanthocytosis in northern México

    L. Hernández Salomón, S. Flores Casas, J. Mejía Chávez, S. Murillo Quintana, D. Sánchez Galván (Torreón, Coahuila, Mexico)

    Objective: This is the first reported case of choreoacanthocytosis with molecular confirmation in northern Mexico, which also presented a previously unreported variant in genetic databases.…
  • 2025 International Congress

    Uncommon Presentation of Moyamoya Disease (MMD): A Case of Negative Myoclonus

    S. Park (Daejeon, Republic of Korea)

    Objective: We describe a case of MMD in which the patient presented with negative myoclonus. Background: Moyamoya disease (MMD) is a progressive cerebrovascular disorder characterized…
  • 2025 International Congress

    A Case of Decreased Disability After Stroke: Lesional Modulation of Essential Tremor

    A. Welleford, T. Yamasaki, D. Ionel (Lexington, USA)

    Objective: We present a case of decreased disability following acute ischemic stroke and review lesional treatment of essential tremor. Background: Essential tremor is one of…
  • 2025 International Congress

    Successful Treatment of Hemifacial Spasm with Daxibotulinum Toxin A

    HS. Lee (Sacramento, USA)

    Objective: Botulinum toxin has been an effective and safe treatment option for hemifacial spasm. This is a report of 5 patients with successful treatment of…
  • 2025 International Congress

    Painful Legs Moving Toes Syndrome in Rural Western India: Etiological Spectrum and Outcomes in 24 Cases

    S. Desai, D. Desai (Anand, India)

    Objective: To characterize clinical profiles, etiological patterns, and therapeutic outcomes of Painful Legs Moving Toes syndrome [PLMTS] patients in a rural Indian neurology practice. Background:…
  • « Previous Page
  • 1
  • …
  • 62
  • 63
  • 64
  • 65
  • 66
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley